Status: Recruiting
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
The purpose of this study is to determine if the radiotracer, \[68Ga\]Ga-ABY-025, used for PET imaging can help us better identify and visualize lesions or tumors, in patients who are receiving standard of care therapy HER2+ cancers.
Participants needed: 30
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Vanderbilt-Ingram Cancer CenterUpdated: May 8, 2026Locations: 1
Eligibility criteria
Age ≥ 18 years. [+4]
Measurable sites of disease only in the liver. [+6]